Methoxyestradiols mediate the antimitogenic effects of estradiol on vascular smooth muscle cells via estrogen receptor-independent mechanisms

Raghvendra K. Dubey, Delbert G. Gillespie, Lefteris C. Zacharia, Marinella Rosselli, Kenneth R. Korzekwa, Juergen Fingerle, Edwin K. Jackson

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

Estrogen receptors (ERs) are widely held to mediate the ability of 17β-estradiol (estradiol) to attenuate injury-induced proliferation of vascular smooth muscle cells (VSMCs) leading to vascular lesions. However, recent findings that estradiol prevents injury-induced vascular lesion formation in knockout mice lacking either ERα or ERβ seriously challenge this concept. Here we report that the local metabolism of estradiol to methoxyestradiols, endogenous metabolites of estradiol with no affinity for ERs, is responsible for the ER-independent inhibitory effects of locally applied estradiol on rat VSMC growth. These finding imply that local vascular estradiol metabolism may be an important determinant of the cardiovascular protective effects of circulating estradiol. Thus, interindividual differences, either genetic or acquired, in the vascular metabolism of estradiol may define a given female's risk of cardiovascular disease and influence the cardiovascular benefit she receives from estradiol replacement therapy in the postmenopausal state. These findings also imply that nonfeminizing estradiol metabolites may confer cardiovascular protection in both women and men. (C) 2000 Academic Press.

Original languageEnglish
Pages (from-to)27-33
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume278
Issue number1
DOIs
Publication statusPublished - 11 Nov 2000

Keywords

  • Cardiovascular disease
  • Hormone replacement therapy
  • Menopause
  • Metabolism
  • Vascular remodeling

Cite this